FDA.reportPublic FDA data

HYPROMELLOSE 2208 (100000 MPA.S)

Substance profile for UNII VM7F0B23ZI, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
VM7F0B23ZI
Preferred term
HYPROMELLOSE 2208 (100000 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300448
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300448https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300448
FDA Substance Registration SystemVM7F0B23ZIhttps://precision.fda.gov/uniisearch/srs/unii/VM7F0B23ZI

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIThese highlights do not include all the information needed to use DUAVEE safely and effectively. See full prescribing information for DUAVEE. DUAVEE ® (conjugated estrogens/bazedoxifene) tablets for oral use Initial U.S. approval: 20131
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDrug Facts1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITheophylline Extended-Release Tablets1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZISenophylline8
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]1001
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIJANUMET XR (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.]16
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PERNIX THERAPEUTICS]14
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE (DEXTROAMPHETAMINE SULFATE) CAPSULE, EXTENDED RELEASE [MALLINCKRODT, INC.]11
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIKHEDEZLA EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [PAR PHARMACEUTICAL INC.]10
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIOXYMORPHONE HYDROCHLORIDE EXTENDED-RELEASE (OXYMORPHONE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.]9
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDESVENLAFAXINE EXTENDED-RELEASE (DESVENLAFAXINE) TABLET, EXTENDED RELEASE [MACOVEN PHARMACEUTICALS]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-SULTING TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]7
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]6
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDOLORACIN/L RX WITH LIDOCAINE (METHYL SALICYLATE, MENTHOL, CAPSAICIN AND LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]5
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [PLIVA INC.]5
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM / L WITH LIDOCAINE RX (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [AUROBINDO PHARMA LIMITED]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]4
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDOLORACIN RX (METHYL SALICYLATE, MENTHOL AND CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM / L WITH LIDOCAINE (METHYL SALICYLATE MENTHOL CAPSAICIN LIDOCAINE) CREAM [TWO HIP CONSULTING, LLC]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [CARDINAL HEALTH]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [UNIT DOSE SERVICES]3
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIDUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE) TABLET, FILM COATED [U.S. PHARMACEUTICALS]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF (METHYL SALICYLATE, MENTHOL, CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITOPICAL PAIN RELIEF RX (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]2
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMEDI-DERM TOPICAL PAIN RELIEF (METHYL SALICYLATE MENTHOL CAPSAICIN) CREAM [TWO HIP CONSULTING, LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE (THEOPHYLLINE) TABLET, EXTENDED RELEASE [AVKARE, INC.]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [MAJOR PHARMACEUTICALS]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZITHEOPHYLLINE TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
HYPROMELLOSE 2208 (100000 MPA.S)INACTIVE INGREDIENTVM7F0B23ZIXIGDUO XR (DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII VM7F0B23ZI page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653CAPSULEORAL161 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653CAPSULE, EXTENDED RELEASEORAL900 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLETORAL1296 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLET, EXTENDED RELEASEORAL2147 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653TABLET, FILM COATED, EXTENDED RELEASEORAL1320 mg
HYPROMELLOSE 2208 (100000 MPA.S)VM7F0B23ZI9004653LOTIONTOPICAL7 mg